Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.10.710798

Exploring Links between Brain Image-Derived Phenotypes and Accelerometer-Measured Physical Activity in the UK Biobank

Abstract

A broad range of neurodegenerative disorders are associated with altered functional connectivity (FC) patterns and atrophy of gray matter volume (GMV). Similarly, there are links between physical activity (PA) and a number of neurodegenerative disorders. However, studies investigating the link between brain image-derived phenotypes (IDPs) and PA remain limited. Using data from the UK Biobank, we investigated the multivariate association between two sets of brain IDPs (related to FC and GMV) and PA using canonical correlation analysis (CCA). We further quantified the importance of individual PA variables in modeling each set of IDPs using both supervised and unsupervised approaches, and assessed their predictive performance for individual brain phenotypes. Finally, we evaluated the predictive performance of brain IDPs and PA variables for diabetes, stroke, coronary heart disease (CHD), and cancer using nested logistic regression models, with their relative contributions to explained variation in disease status quantified using a coefficient of determination specifically designed for logistic regression. Our analyses identified a statistically robust but low-dimensional axis of shared variation between PA and FC (canonical correlation r = 0.50), whereas the corresponding association between PA and GMV was weaker (r = 0.19). Brain features contributing most strongly to these associations were located in motor- and attention-related networks. Across predictive models, a small set of correlated PA measures reflecting activity intensity and circadian rhythm consistently emerged as representative predictors of both FC and GMV variation. Finally, we found that PA variables demonstrated greater predictive utility than either FC or GMV alone, particularly for CHD and diabetes, as assessed by both the area under the receiver operating characteristic (ROC) curve (AUC) and the proportion of explained variation. Together, these findings indicate that objectively measured PA is strongly associated with a set of motor-related brain features and provides substantial predictive information for cardiometabolic disease risk, while cross-sectional neuroimaging measures offer more modest incremental explanatory value.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, D., Leroux, A., Crainiceanu, C. M., Lindquist, M. A.. 2026-03-11. Exploring Links between Brain Image-Derived Phenotypes and Accelerometer-Measured Physical Activity in the UK Biobank. https://doi.org/10.64898/2026.03.10.710798

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗